Death Waits for No Man--does It Wait for a Virus? How Enteroviruses Induce and Control Cell Death

Overview

Journal Cytokine Growth Factor Rev

Date 2014 Aug 31

PMID 25172372

Citations 16

Authors

Katharine G Harris

Carolyn B Coyne

Affiliations

Soon will be listed here.

Abstract

Enteroviruses (EVs) are the most common human viral pathogens. They cause a variety of pathologies, including myocarditis and meningoencephalopathies, and have been linked to the onset of type I diabetes. These pathologies result from the death of cells in the myocardium, central nervous system, and pancreas, respectively. Understanding the role of EVs in inducing cell death is crucial to understanding the etiologies of these diverse pathologies. EVs both induce and delay host cell death, and their exquisite control of this balance is crucial for their success as human viral pathogens. Thus, EVs are tightly involved with cell death signaling pathways and interact with host cell signaling at multiple points. Here, we review the literature detailing the mechanisms of EV-induced cell death. We discuss the mechanisms by which EVs induce cell death, the signaling pathways involved in these pathways, and the strategies by which EVs antagonize cell death pathways. We also discuss the role of cell death in both the resulting pathology in the host and in the facilitation of viral spread.

Citing Articles

MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.

Rani P, George B, V S, Biswas S, V M, Pal A J Virol. 2024; 98(2):e0150423.

PMID: 38289119 PMC: 10883805. DOI: 10.1128/jvi.01504-23.

Advances in anti-EV-A71 drug development research.

Wang S, Pang Z, Fan H, Tong Y J Adv Res. 2023; 56:137-156.

PMID: 37001813 PMC: 10834817. DOI: 10.1016/j.jare.2023.03.007.

"Flash & Click": Multifunctionalized Lipid Derivatives as Tools To Study Viral Infections.

Schultz C, Farley S, Tafesse F J Am Chem Soc. 2022; 144(31):13987-13995.

PMID: 35900117 PMC: 9377334. DOI: 10.1021/jacs.2c02705.

Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies.

Ho H, Peischard S, Strutz-Seebohm N, Klingel K, Seebohm G Viruses. 2021; 13(9).

PMID: 34578462 PMC: 8473126. DOI: 10.3390/v13091880.

Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?.

Stone V, Ringqvist E, Larsson P, Domsgen E, Holmlund U, Sverremark-Ekstrom E Microorganisms. 2021; 9(1).

PMID: 33466313 PMC: 7824802. DOI: 10.3390/microorganisms9010105.

References

Taylor M, Burgon T, Kirkegaard K, Jackson W . Role of microtubules in extracellular release of poliovirus. J Virol. 2009; 83(13):6599-609. PMC: 2698579. DOI: 10.1128/JVI.01819-08. View

Pavio N, Couderc T, Girard S, Sgro J, Blondel B, Colbere-Garapin F . Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus. Virology. 2000; 274(2):331-42. DOI: 10.1006/viro.2000.0462. View

Castelli J, Hassel B, Wood K, Li X, Amemiya K, Dalakas M . A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med. 1997; 186(6):967-72. PMC: 2199051. DOI: 10.1084/jem.186.6.967. View

Neznanov N, Chumakov K, Ullrich A, Agol V, Gudkov A . Unstable receptors disappear from cell surface during poliovirus infection. Med Sci Monit. 2002; 8(10):BR391-6. View

Autret A, Martin-Latil S, Mousson L, Wirotius A, Petit F, Arnoult D . Poliovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase. J Virol. 2007; 81(14):7504-16. PMC: 1933371. DOI: 10.1128/JVI.02690-06. View

Croall D, Ersfeld K . The calpains: modular designs and functional diversity. Genome Biol. 2007; 8(6):218. PMC: 2394746. DOI: 10.1186/gb-2007-8-6-218. View

Yoon J, Austin M, Onodera T, Notkins A . Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979; 300(21):1173-9. DOI: 10.1056/NEJM197905243002102. View

Dotta F, Censini S, van Halteren A, Marselli L, Masini M, Dionisi S . Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A. 2007; 104(12):5115-20. PMC: 1829272. DOI: 10.1073/pnas.0700442104. View

Ruller C, Tabor-Godwin J, Van Deren Jr D, Robinson S, Maciejewski S, Gluhm S . Neural stem cell depletion and CNS developmental defects after enteroviral infection. Am J Pathol. 2012; 180(3):1107-1120. PMC: 3349883. DOI: 10.1016/j.ajpath.2011.11.016. View

10.

Autret A, Martin-Latil S, Brisac C, Mousson L, Colbere-Garapin F, Blondel B . Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death. J Virol. 2008; 82(7):3796-802. PMC: 2268503. DOI: 10.1128/JVI.02020-07. View

11.

Hanafusa T, Imagawa A . Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab. 2006; 3(1):36-45. DOI: 10.1038/ncpendmet0351. View

12.

Upton J, Chan F . Staying alive: cell death in antiviral immunity. Mol Cell. 2014; 54(2):273-80. PMC: 4010939. DOI: 10.1016/j.molcel.2014.01.027. View

13.

Xin L, Xiao Z, Ma X, He F, Yao H, Liu Z . Coxsackievirus B3 induces crosstalk between autophagy and apoptosis to benefit its release after replicating in autophagosomes through a mechanism involving caspase cleavage of autophagy-related proteins. Infect Genet Evol. 2014; 26:95-102. DOI: 10.1016/j.meegid.2014.05.005. View

14.

Martin J, Dunn G, Hull R, Patel V, Minor P . Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol. 2000; 74(7):3001-10. PMC: 111798. DOI: 10.1128/jvi.74.7.3001-3010.2000. View

15.

Lloyd R, Bovee M . Persistent infection of human erythroblastoid cells by poliovirus. Virology. 1993; 194(1):200-9. DOI: 10.1006/viro.1993.1250. View

16.

Maisch B, Berg P, Kochsiek K . Autoantibodies and serum inhibition factors (sif) in patients with myocarditis. Klin Wochenschr. 1980; 58(5):219-25. DOI: 10.1007/BF01476967. View

17.

Kim R, Emi M, Tanabe K, Murakami S . Role of the unfolded protein response in cell death. Apoptosis. 2005; 11(1):5-13. DOI: 10.1007/s10495-005-3088-0. View

18.

Campanella M, de Jong A, Lanke K, Melchers W, Willems P, Pinton P . The coxsackievirus 2B protein suppresses apoptotic host cell responses by manipulating intracellular Ca2+ homeostasis. J Biol Chem. 2004; 279(18):18440-50. DOI: 10.1074/jbc.M309494200. View

19.

Ahn J, Joo C, Seo I, Kim D, Kim Y, Lee H . All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol. 2004; 75(2):290-4. DOI: 10.1002/jmv.20269. View

20.

Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M . Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009; 58(10):2285-91. PMC: 2750208. DOI: 10.2337/db09-0091. View